Show
Sort by
-
- Miscellaneous
- open access
Dupilumab efficacy and biomarkers in chronic rhinosinusitis with nasal polyps : association between dupilumab treatment effect on nasal polyp score and biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps in the phase 3 SINUS‐24 and SINUS‐52 trials
-
- Conference Paper
- C3
- open access
Dupilumab reduces blood and nasal biomarkers of type 2 inflammation in patients with chronic rhinosinusitis with nasal polyps with and without comorbid asthma : SINUS-52 trial
-
- Journal Article
- A1
- open access
Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis
-
- Journal Article
- A1
- open access
Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma
-
- Journal Article
- A1
- open access
Dupilumab efficacy in uncontrolled, moderate-to-severe asthma with self-reported chronic rhinosinusitis